MIRA Pharmaceuticals, Inc. - Common Stock (MIRA)

In today's session, these stocks are experiencing unusual volume.

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

MIRA Pharmaceuticals shares are trading significantly higher on Thursday following the announcement of new preclinical data for its lead candidate Mira-55.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Mira Pharmaceuticals shares surged 68.94% in after-hours trading after the company reported promising preclinical results for its pain treatment candidate, Mira-55.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Discover the stocks with unexpected trading volume in today's session on the US markets.

The trading volume of these stocks is deviating from the norm in today's session.

U.S. stock futures were slightly higher on Thursday after a mixed close on Wednesday. Futures of major benchmark indices were trading higher.

MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future development.

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.